Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Dentine Hypersensitivity
Total 0 results
Nothing found
Sponsors and Collaborators
Radiomedix, Inc.
Private Ortopedia Hospital, Seyhan Adana
National Institute of Health and Medical Research 1061, Montpellier
Accunea Ltd.
Zhiwu Huang, Ph.D.
Association for the Blind and Visually Impaired
Mitaka USA, Inc.
Key Tech
Refocus Group, Inc.
APT Foundation, Inc.
Congressionally Directed Medical Research Programs
Aryn Knight
Erol Aktunc
LuEsther T. Mertz Retinal Research Center
Lishui Hospital of TCM
Francine Behar-Cohen
Cure Cancer Worldwide Corporation
Richard M. Fairbanks School of Public Health AT IUPUI
Third Affiliated Hospital of Third Military Medical University
Central Institute of Psychiatry, Ranchi, India
View Full List
Medical Conditions
Root Abscess
Poor Medication Adherence
Atherosclerosis Coronary Artery With Angina Pectoris
Macrocephaly Autism Syndrome
Memory Disorders
Endoscopic Surveillance
Humerus Fracture Displaced Proximal
0.5-14 Year Old Children With Nephroblastoma
Small Intestine Cancer
Pharmacokinetics of Ipragliflozin
Bladder Recurrence
Neuroectodermal Tumor
Granulomatous Disease, Chronic
Parental
Malignant Tumor of Urinary System (Disorder)
Control Nausea and Vomiting
Inoperable Stage III Non-small Cell Lung Cancer
Anticoagulant Prophylaxis/Therapy
Urinary Bladder Neurogenic Dysfunction
Bladder Cancer Recurrent
View Full List
Drug Interventions
Idelalisib
Sparsentan
APG2575 800 mg
Campath 1H
Letrozole
Biphasic insulin aspart 30
Bupropion Extended Release Oral Tablet
Vehicle
Elafibranor 80mg
Fibrin Sealant
Cyclosporine A
Varenicline Controlled Release 1.2 mg
Clozapine 100 mg
Salvinorin A
Everolimus
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
FTD regimen
Ceralasertib
SAR408701 (Tusamitamab ravtansine)
The drug "Rutan 0.1".
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Canada
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Denmark
Contract Research Organizations in Jamaica
Contract Research Organizations in Japan
Contract Research Organizations in Latvia
Contract Research Organizations in Mozambique
Contract Research Organizations in Oman
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Togo
Contract Research Organizations in Turkmenistan
Contract Research Organizations in United States
CRO list by country
CROs in Finland
Medfiles
IRW Consulting
ProPharma Group
Dokumeds
LINK Medical
Parexel
SGS
IQVIA
Charles River Laboratories
Smerud Medical Research Group
All CROs in Finland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe